Details for New Drug Application (NDA): 214089
The generic ingredient in MEXILETINE HYDROCHLORIDE is mexiletine hydrochloride. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the mexiletine hydrochloride profile page.
Summary for 214089
| Tradename: | MEXILETINE HYDROCHLORIDE |
| Applicant: | Pharmazone |
| Ingredient: | mexiletine hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 214089
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 214089 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-955 | 62756-955-01 | 100 CAPSULE in 1 BOTTLE (62756-955-01) |
| MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 214089 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-956 | 62756-956-01 | 100 CAPSULE in 1 BOTTLE (62756-956-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 150MG | ||||
| Approval Date: | Oct 1, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
| Approval Date: | Oct 1, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Oct 1, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
